2022
DOI: 10.32604/oncologie.2022.024373
|View full text |Cite
|
Sign up to set email alerts
|

A UHPLC/MS/MS Assay Based on an Isotope-Labeled Peptide for Sensitive miR-21 Detection in HCC Serum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…This requires more in-depth studies on the mechanism of action of TUBB in LIHC in the future. The above results indicated that the risk model based on these 4 genes had a strong reliability for LIHC patient’s diagnosis and prognosis, and their detection in biological samples such as serum [ 62 ] or urine may be prospective.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This requires more in-depth studies on the mechanism of action of TUBB in LIHC in the future. The above results indicated that the risk model based on these 4 genes had a strong reliability for LIHC patient’s diagnosis and prognosis, and their detection in biological samples such as serum [ 62 ] or urine may be prospective.…”
Section: Discussionmentioning
confidence: 99%
“…had a strong reliability for LIHC patient's diagnosis and prognosis, and their detection in biological samples such as serum [62] or urine may be prospective.…”
Section: Plos Onementioning
confidence: 99%
“…Despite advances in the treatment of liver cancer [ 6 ], most patients with HCC do not respond well to cell programmed death 1 (anti-PD1) therapy [ 7 ]. Therefore, the identification of key molecular features [ 8 ] with advanced techniques [ 9 , 10 ] related to HCC is helpful for the specific mechanism research of HCC, and may provide new ideas for the search for more potential therapeutic targets and prognostic diagnosis in the future.…”
Section: Introductionmentioning
confidence: 99%
“…A variety of factors such as lack of curative treatment in patients with early detection, inadequate early detection strategies, inconsistent application of curative treatment and concurrent liver disease all contribute to a high death rate of HCC patients [ 8 ]. Further substantial reduction of HCC cases requires more widespread use of effective treatment of HBV and HCV-related chronic hepatitis and liver cirrhosis, reduction of alcohol consumption, more effective exercise, universal HBV vaccination, promotion of correct eating habits, and enhanced understanding of the molecular biology of HCC [ [9] , [10] , [11] ].…”
Section: Introductionmentioning
confidence: 99%